VT
Volastra Therapeutics, Inc.
SEC filingPharmaceuticals · New York, NY
Amount raised$30.1Msold at filing
Total offering$30.1M
Investors in the raise11count reported to the SEC
FiledSep 23, 2025first sale Sep 8, 2025
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Sandra PetersonDirector
Robert MittendorffDirector
Jill GoldsteinDirector
David SouthwellExecutive Officer, Director
Arjun BalarDirector
Samuel BakhoumDirector
Ellie McGuireDirector
Luc DochezDirector
David NicholsonDirector
Executive officers, directors and promoters as listed on the Form D.